Skip to content

Effect of high-frequency rTMS on patients with leg paralysis

Effect of high-frequency rTMS on patients with leg paralysis - Effect of high-frequency rTMS on patients with leg paralysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038420
Enrollment
10
Registered
2021-07-07
Start date
2019-11-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

High-frequency repetitive transcranial magnetic stimulation on lower limb area

Sponsors

Motoyama Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The lesion does not extend to the cerebral cortex In the case of cerebral hemorrhage after 0 days after onset, hematoma is absorbed 10m walk is possible by walking alone (balance ability is not included. Contact assistance is also possible) No history of epilepsy or seizures Metals close to the stimulation site (stimulators such as cochlear implants, magnetic clips, deep brain stimulation and vagus nerve stimulation), without a cardiac pacemaker Intracranial titanium products, or magnetically mounted dentures, without implants Intracranial lesions at risk for seizures There is no Those who have not taken medications that lower the seizure threshold (such as tricyclic antidepressants, maprotiline, theophylline, methylphenidate, ketamine, clozapine, zotepine). Those who are not complicated by serious physical illness during pregnancy, abuse, withdrawal of alcohol, caffeine or stimulant. Those who do not have cognitive decline or higher brain damage that may affect or be dangerous in the intervention of this study

Exclusion criteria

Exclusion criteria: The lesion does not extend to the cerebral cortex In the case of cerebral hemorrhage after 0 days after onset, hematoma is absorbed 10m walk is possible by walking alone (balance ability is not included. Contact assistance is also possible) No history of epilepsy or seizures Metals close to the stimulation site (stimulators such as cochlear implants, magnetic clips, deep brain stimulation and vagus nerve stimulation), without a cardiac pacemaker Intracranial titanium products, or magnetically mounted dentures, without implants Intracranial lesions at risk for seizures There is no Those who have not taken medications that lower the seizure threshold (such as tricyclic antidepressants, maprotiline, theophylline, methylphenidate, ketamine, clozapine, zotepine). Those who are not complicated by serious physical illness during pregnancy, abuse, withdrawal of alcohol, caffeine or stimulant. Those who do not have cognitive decline or higher brain damage that may affect or be dangerous in the intervention of this study

Design outcomes

Primary

MeasureTime frame
Brunnstrom recovery stage Fugl-Meyer assessment Modified Ashworth Scale Functional Reach Test Timed Up and Go test 10m gait Functional balance scale BESTEST Functional Ambulation Categories Functional Independence Measure

Countries

Japan

Contacts

Public ContactYoshiyuki Sakoda

Motoyama Rehabilitation Hospital rehabilitation

sako19920707@gmail.com0784128080

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026